Treatment of cancer-related illnesses
10mg/1 ml & 50mg/1 ml
Solution for injection. Indication: Non-Small Cell Lung Cancer/Advanced Breast Cancer
20mg & 30mg
In capsule form. Indication: Non-Small Cell Lung Cancer/Advanced Breast Cancer
3.75mg & 11.25mg & 22.5mg
Pamorelin Powder for Suspension for Injection.
Indication: For the treatment of locally advanced or metastatic, hormone-dependent prostrate cancer
50mg/2 ml & 250mg/10 ml
Concentrate for solution for infusion.
Indication: as monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract